These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2290463)

  • 21. HTLVI antibodies in multiple sclerosis and other neurological diseases.
    Ferrante P; Seresella M; Cocuzza CE; Caputo D; Cattaneo E; Achilli G; Cazzullo CL
    Acta Neurol (Napoli); 1990 Feb; 12(1):95-9. PubMed ID: 2337003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis.
    Gorczyca WA; Ejma M; Witkowska D; Misiuk-Hojło M; Kuropatwa M; Mulak M; Szymaniec S
    Ophthalmic Res; 2004; 36(2):120-3. PubMed ID: 15017109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
    Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
    Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmunity in multiple sclerosis.
    De Keyser J
    Neurology; 1988 Mar; 38(3):371-4. PubMed ID: 3347339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis.
    Ioppoli C; Meucci G; Mariotti S; Martino E; Lippi A; Gironelli L; Pinchera A; Muratorio A
    Ital J Neurol Sci; 1990 Feb; 11(1):31-6. PubMed ID: 2332323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies against pituitary peptides in sera from patients with multiple sclerosis.
    Hansen BL; Hansen GN; Hagen C; Brodersen P
    J Neuroimmunol; 1983 Oct; 5(2):171-83. PubMed ID: 6352740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Search for autoantibodies to endothelial and smooth muscle cells in patients with multiple sclerosis.
    Tsukada N; Behan WM; Behan PO
    Acta Neuropathol; 1985; 66(2):134-9. PubMed ID: 3874512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies.
    Spadaro M; Amendolea MA; Mazzucconi MG; Fantozzi R; Di Lello R; Zangari P; Masala G
    Mult Scler; 1999 Apr; 5(2):121-5. PubMed ID: 10335521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do elevated autoantibodies in patients with multiple sclerosis matter?
    Dal-Bianco A; Wenhoda F; Rommer PS; Weber M; Altmann P; Kraus J; Leutmezer F; Salhofer-Polanyi S
    Acta Neurol Scand; 2019 Mar; 139(3):238-246. PubMed ID: 30447159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pathogenetic role of circulating immune complexes in multiple sclerosis].
    Dziuba AN; Frolov VM; Peresadin NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(2):53-5. PubMed ID: 7941893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA aptamer against autoantibodies associated with multiple sclerosis and bioluminescent detection probe on its basis.
    Vorobjeva MA; Krasitskaya VV; Fokina AA; Timoshenko VV; Nevinsky GA; Venyaminova AG; Frank LA
    Anal Chem; 2014 Mar; 86(5):2590-4. PubMed ID: 24512542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study.
    Tourbah A; Clapin A; Gout O; Fontaine B; Liblau R; Batteux F; Stiévenart JL; Weill B; Lubetzki C; Lyon-Caen O
    Arch Neurol; 1998 Apr; 55(4):517-21. PubMed ID: 9561980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to brain tissue in sera of patients with chronic progressive multiple sclerosis.
    Henneberg A; Mayle DM; Kornhuber HH
    J Neuroimmunol; 1991 Nov; 34(2-3):223-7. PubMed ID: 1918328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis.
    Del Boccio P; Pieragostino D; Di Ioia M; Petrucci F; Lugaresi A; De Luca G; Gambi D; Onofrj M; Di Ilio C; Sacchetta P; Urbani A
    J Proteomics; 2011 Nov; 74(12):2826-36. PubMed ID: 21757039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are there antilymphocyte autoantibodies in multiple sclerosis patients?
    Fischer EG; Ahlers F; Kornhuber HH; Henneberg A
    J Neurol Sci; 1989 Nov; 93(2-3):319-22. PubMed ID: 2592989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis and other immunologic diseases.
    Seyfert S; Klapps P; Meisel C; Fischer T; Junghan U
    Acta Neurol Scand; 1990 Jan; 81(1):37-42. PubMed ID: 2330813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Sclerosis and Antibodies against KIR4.1.
    Pröbstel AK; Kuhle J; Lecourt AC; Vock I; Sanderson NS; Kappos L; Derfuss T
    N Engl J Med; 2016 Apr; 374(15):1496-8. PubMed ID: 27074084
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating autoantibodies in patients with fibrocystic disease of the breast.
    Tsakraklides E; Anastassiades OT; Gogas J; Renieri N
    J Cancer Res Clin Oncol; 1983; 106(3):219-21. PubMed ID: 6654956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers in multiple sclerosis: role of antibodies.
    Berger T; Reindl M
    Dis Markers; 2006; 22(4):207-12. PubMed ID: 17124342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.